Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
AOD 9604: Budget alternative for fat loss Why it's a good option: Specifically targets fat metabolism No appetite suppression (pro or con) Cheaper than GLP-1s Fewer side effects Best for: Modest fat loss Those who can't tolerate GLP-1 side effects Budget-conscious Don't need appetite control Dosing: 300-600mcg daily on empty stomach Injectable subcutaneous Use for 3-6 months Less powerful than GLP-1s: Expect 5-10 lbs loss over 3 months (vs 15-25 lbs with semaglutide) Better than nothing, not as effective as GLP-1s See our AOD 9604 guide and HGH fragment 176-191 calculator
However, topical application with microneedling can significantly enhance absorption, approaching injectable effectiveness for some users
We also assess key biomarkers to identify your unique peptide needs
\n\n\n\n BPC-157 Safety and Tolerability: What the Research Shows \n\n\n\n Based on the available preclinical literature, BPC-157 has demonstrated a favorable safety profile in animal models, with no significant toxicity reported even at relatively high exposure levels over extended study periods
GLP-1R activation by retatrutide promotes glucose-dependent insulin secretion, suppresses glucagon during hyperglycemia, delays gastric emptying, and reduces appetite via CNS signaling
